Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment

J. Ichikawa*, H. Y. Meltzer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Chronic administration of haloperidol (2 mg/kg × 21 days) in drinking water decreased basal dopamine (DA) release and metabolism in rat striatum and nucleus accumbens in awake, freely moving rats. In contrast with previous in vivo voltammetric studies in chloral hydrate-anesthetized rats, DA release and metabolism decreased in both regions following administration of (-)apomorphine (50 μg/kg, i.v.). These results demonstrate that stimulation of pre- or postsynaptic DA receptors by apomorphine i n rats chronically treated with haloperidol further diminishes the release of DA and decreases DA metabolism. These results are difficult to reconcile with current concepts of neuroleptic-induced depolarization inactivation which predict increased release of DA following DA agonist administration.

Original languageEnglish (US)
Pages (from-to)138-142
Number of pages5
JournalBrain research
Volume507
Issue number1
DOIs
StatePublished - Jan 15 1990

Keywords

  • Apomorphine
  • Autoreceptor
  • Chronic haloperidol
  • Dopamine release
  • Microdialysis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment'. Together they form a unique fingerprint.

Cite this